Serum Melatonin at Admission and Discharge in Schizophrenia: A Prospective Longitudinal Controlled Study
- 1Department of Internal Medicine, Dermatology, and Psychiatry, University of La Laguna (ULL), 38320 Santa Cruz de Tenerife, Canary Islands, Spain
- 2Department of Psychiatry, University Hospital of the Canary Islands, 38320 Tenerife, Canary Islands, Spain
- 3Department of Basic Medical Sciences, University of La Laguna (ULL), 38320 Santa Cruz de Tenerife, Canary Islands, Spain
Abstract
Schizophrenia is associated with circadian and neuroendocrine disturbances, but whether circulating melatonin changes with acute clinical state remains uncertain. This prospective longitudinal controlled study measured serum melatonin at 12:00 and 00:00 in 43 hospitalized patients after admission and before discharge, and during one session in 42 healthy controls. Psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). Nonparametric comparisons used family-specific Holm adjustment; exploratory correlations used false-discovery-rate control. In comparisons without covariate adjustment, midday concentrations were higher in patients at admission and discharge (Holm p = 0.013 and 0.007), but the differences did not remain significant after Holm correction in exploratory models adjusted for BMI, age, and sex (29 patients and 40 controls). Median within-patient changes were −0.14 pg/mL at 12:00 (95% CI −0.27 to 0.74) and 0.00 pg./mL at 00:00 (95% CI −2.00 to 6.35); both Holm p = 1.000. Total PANSS decreased by a median of 14 points among 24 complete pairs. No change-PANSS correlation survived multiplicity correction. Two daily samples demonstrate a midday–midnight concentration difference but cannot characterize circadian phase, amplitude, or total secretion. No short-term melatonin change was detected during hospitalization; this does not establish equivalence or confirm or exclude trait-biomarker status. State-marker utility remains uncertain, and patient–control differences may reflect medication, smoking, or confounding by assay plate.
Related
- Longitudinal Changes in Serum Interleukin-33 Levels During Acute Psychotic Relapse and Clinical Improvement in Schizophrenia: An Admission-Discharge Study
- Longitudinal Clinical and Functional Outcomes in Adult-Onset Delusional Disorder and Schizophrenia: A 10-Year Prospective Comparison Study
- A pilot randomized controlled trial of melatonin supplementation on plasma 2-arachidonoylglycerol, ghrelin, and hedonic appetite intensity in females with overweight/obesity
- Plasma Vitamin C, 25-Hydroxyvitamin D, and the Lactate-to-Albumin Ratio at PICU Admission in Survivors and Non-Survivors of Phoenix-Defined Pediatric Sepsis and Septic Shock: An Exploratory Prospective Cohort Study
- Ultra-rare coding variants in schizophrenia risk genes are associated with longitudinal phenotypic differences across psychotic disorders
BibTeX
@article{morerafumero2026serum,
title = {{Serum Melatonin at Admission and Discharge in Schizophrenia: A Prospective Longitudinal Controlled Study}},
author = {Armando Luis Morera-Fumero and Estefanía Diaz-Mesa and Silvia Yelmo-Cruz and Pedro Abreu-González and María Lourdes Fernández-López},
journal = {Biomolecules},
year = {2026},
month = oct,
doi = {10.3390/biom16101438},
url = {https://www.mdpi.com/2218-273X/16/10/1438},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Serum Melatonin at Admission and Discharge in Schizophrenia: A Prospective Longitudinal Controlled Study
AU - Armando Luis Morera-Fumero
AU - Estefanía Diaz-Mesa
AU - Silvia Yelmo-Cruz
AU - Pedro Abreu-González
AU - María Lourdes Fernández-López
PY - 2026
DA - 2026/10/01
JO - Biomolecules
DO - 10.3390/biom16101438
UR - https://www.mdpi.com/2218-273X/16/10/1438
AB - Schizophrenia is associated with circadian and neuroendocrine disturbances, but whether circulating melatonin changes with acute clinical state remains uncertain. This prospective longitudinal controlled study measured serum melatonin at 12:00 and 00:00 in 43 hospitalized patients after admission and before discharge, and during one session in 42 healthy controls. Psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). Nonparametric comparisons used family-specific Holm adjustment; exploratory correlations used false-discovery-rate control. In comparisons without covariate adjustment, midday concentrations were higher in patients at admission and discharge (Holm p = 0.013 and 0.007), but the differences did not remain significant after Holm correction in exploratory models adjusted for BMI, age, and sex (29 patients and 40 controls). Median within-patient changes were −0.14 pg/mL at 12:00 (95% CI −0.27 to 0.74) and 0.00 pg./mL at 00:00 (95% CI −2.00 to 6.35); both Holm p = 1.000. Total PANSS decreased by a median of 14 points among 24 complete pairs. No change-PANSS correlation survived multiplicity correction. Two daily samples demonstrate a midday–midnight concentration difference but cannot characterize circadian phase, amplitude, or total secretion. No short-term melatonin change was detected during hospitalization; this does not establish equivalence or confirm or exclude trait-biomarker status. State-marker utility remains uncertain, and patient–control differences may reflect medication, smoking, or confounding by assay plate.
SN - 2218-273X
ER -